Susquehanna International Group, LLP Pmv Pharmaceuticals, Inc. Put Options Transaction History

Susquehanna International Group, LLP

5 transactions

Quarter	Operation	Price Per put	puts change	puts Held
Q4 2023 Feb 14, 2024	SELL	$1.23 - $6.6 $296,922 - $1.59 Million	-241,400 Reduced 94.96%	12,800 $39,000
Q3 2023 Nov 14, 2023	BUY	$6.01 - $8.93 $1.53 Million - $2.27 Million	254,200 New	254,200 $1.56 Million
Q1 2023 May 16, 2023	SELL	$4.77 - $9.16 $51,992 - $99,844	-10,900 Reduced 36.21%	19,200 $91,000
Q4 2022 Feb 14, 2023	SELL	$8.17 - $12.95 $4,085 - $6,475	-500 Reduced 1.63%	30,100 $261,000
Q3 2022 Nov 14, 2022	SELL	$11.4 - $17.18 $566,580 - $853,846	-49,700 Reduced 61.89%	30,600 $364,000

41.9M

3.1K

1.7K

Ticker PMVP
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 45,622,600
Market Cap $71.6M
Description
PMV Pharmaceuticals, Inc., a precision oncology company, engages in the discovery and development of small molecule and tumor-agnostic therapies for p53 mutations in cancer. The company's lead product candidate is PC14586, a small molecule that corrects a p53 protein containing the Y220C mutation and restores wild-type p53 function. It is also d...

Get notified when there are updates to the investment portfolio of Susquehanna International Group, LLP, based on Form 13F filings with the SEC.

Stay updated on Susquehanna International Group, LLP with notifications on news.